Afatinib/gefitinib/osimertinibAcquired resistance: 4 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2020年 / 1806卷 / 1期

关键词：

D O I：

10.1007/s40278-020-79039-8

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：21 / 21

相关论文

共 50 条

[21] Atezolizumab/gefitinib/osimertinibAcquired resistance and lack of efficacy: case report
Reactions Weekly, 2022, 1920 (1) : 89 - 89
[22] Icotinib/osimertinibAcquired resistance: 2 case reports
Reactions Weekly, 2021, 1853 (1) : 233 - 233
[23] Afatinib/gefitinib/nivolumabDevelopment of resistance: case report
Reactions Weekly, 2020, 1809 (1) : 14 - 14
[24] Afatinib/gefitinibDevelopment of resistance to gefitinib and afatinib in lung adenocarcinoma: case report
Reactions Weekly, 2019, 1771 (1) : 21 - 21
[25] Afatinib/osimertinibAcquired drug resistance and rebound of brain metastases: case report
Reactions Weekly, 2023, 1983 (1) : 21 - 21
[26] Aumolertinib/osimertinibAcquired drug resistance: 10 case reports
Reactions Weekly, 2023, 1968 (1) : 59 - 59
[27] Alectinib/osimertinibAcquired drug resistance: 11 case reports
Reactions Weekly, 2020, 1818 (1) : 19 - 19
[28] Erlotinib/osimertinibAcquired drug resistance: 2 case reports
Reactions Weekly, 2019, 1753 (1) : 161 - 161
[29] OsimertinibAcquired resistance and acquired genetic alterations: 49 case reports
Reactions Weekly, 2025, 2047 (1) : 364 - 364
[30] Afatinib/bevacizumabAcquired resistance: 8 case reports
Reactions Weekly, 2018, 1726 (1) : 20 - 20

← 1 2 3 4 5 →